Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan

Cold agglutinin disease

Cold Agglutinin Disease Real World Evidence Registry An Open-label Study of ALPN-303 in Subjects With Autoimmune Cytopenias Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD) Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders Therapy for Chronic Cold Agglutinin Disease Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease Therapy of Chronic Cold Agglutinin Disease With Eculizumab